Aju Mathew

1.8k total citations
64 papers, 773 citations indexed

About

Aju Mathew is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Cancer Research. According to data from OpenAlex, Aju Mathew has authored 64 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 15 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Cancer Research. Recurrent topics in Aju Mathew's work include Economic and Financial Impacts of Cancer (10 papers), Global Cancer Incidence and Screening (10 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). Aju Mathew is often cited by papers focused on Economic and Financial Impacts of Cancer (10 papers), Global Cancer Incidence and Screening (10 papers) and Radiopharmaceutical Chemistry and Applications (8 papers). Aju Mathew collaborates with scholars based in United States, India and Italy. Aju Mathew's co-authors include Adam Brufsky, Gurprataap Singh Sandhu, Sebhat Erqou, Senthil Rajappa, Margaret Rosenzweig, Mini E. Jacob, Bin Huang, Feitong Lei, Nancy E. Davidson and Steffi Oesterreich and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Aju Mathew

58 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aju Mathew United States 15 407 185 152 126 113 64 773
Hikmat Abdel‐Razeq Jordan 17 481 1.2× 235 1.3× 195 1.3× 90 0.7× 52 0.5× 155 1.2k
Lucio Gordan United States 14 625 1.5× 153 0.8× 265 1.7× 99 0.8× 137 1.2× 46 1.1k
Luciana Neamţiu Italy 12 435 1.1× 101 0.5× 141 0.9× 76 0.6× 83 0.7× 46 823
Fiona McKenzie France 18 584 1.4× 130 0.7× 110 0.7× 71 0.6× 128 1.1× 31 1.0k
Ariadna Tibau Spain 17 364 0.9× 197 1.1× 129 0.8× 109 0.9× 345 3.1× 51 956
Marta Román Spain 21 724 1.8× 299 1.6× 245 1.6× 171 1.4× 94 0.8× 68 1.2k
John D. Sprandio United States 15 371 0.9× 236 1.3× 251 1.7× 57 0.5× 190 1.7× 27 989
Hans Wildiers Belgium 9 586 1.4× 257 1.4× 263 1.7× 92 0.7× 86 0.8× 33 1.1k
Manuela Quaresma United Kingdom 14 656 1.6× 79 0.4× 164 1.1× 48 0.4× 172 1.5× 29 1.1k
Anna Ceribelli Italy 15 577 1.4× 132 0.7× 449 3.0× 52 0.4× 66 0.6× 35 1.0k

Countries citing papers authored by Aju Mathew

Since Specialization
Citations

This map shows the geographic impact of Aju Mathew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aju Mathew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aju Mathew more than expected).

Fields of papers citing papers by Aju Mathew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aju Mathew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aju Mathew. The network helps show where Aju Mathew may publish in the future.

Co-authorship network of co-authors of Aju Mathew

This figure shows the co-authorship network connecting the top 25 collaborators of Aju Mathew. A scholar is included among the top collaborators of Aju Mathew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aju Mathew. Aju Mathew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jain, Bhav, Puneeth Iyengar, James Fan Wu, et al.. (2025). Hematologic cancers in the SAARC region: current burden in 2022 and projections to 2050. 2(1). 100036–100036.
2.
Mathew, Aju, et al.. (2025). Could Microplastics Be the Reason for the High Gallbladder Cancer Incidence in Northern India?. Indian Journal of Medical and Paediatric Oncology. 46(5). 505–507.
3.
Mathew, Aju, et al.. (2025). Incidence of Cancers in Kerala, India: A Review of Population-Based Registry Data. JCO Global Oncology. 11(11). e2400395–e2400395. 1 indexed citations
4.
Mathew, Aju, et al.. (2024). Implementing large language model-based artificial intelligence (AI) technology in proposing effective treatment plans in patients with cancer.. Journal of Clinical Oncology. 42(16_suppl). e13660–e13660. 3 indexed citations
5.
Mathew, Aju, et al.. (2024). Guiding Principles for Community Building in Global Oncology. American Society of Clinical Oncology Educational Book. 44(3). e100045–e100045. 2 indexed citations
6.
Mathew, Aju, et al.. (2024). Legislation on cancer notification in India: current status. SHILAP Revista de lepidopterología. 21. 100356–100356. 1 indexed citations
7.
8.
9.
Sengar, Manju, Adam Fundytus, Wilma M. Hopman, et al.. (2022). Cancer Medicines: What Is Essential and Affordable in India?. JCO Global Oncology. 8(8). e2200060–e2200060. 11 indexed citations
11.
Mathew, Aju, et al.. (2021). Polycythemia Vera Presenting as Hemorrhagic Stroke. Journal of Neurosciences in Rural Practice. 12(3). 601–602. 2 indexed citations
12.
Panato, Chiara, Salvatore Vaccarella, Luigino Dal Maso, et al.. (2020). Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis. The Journal of Clinical Endocrinology & Metabolism. 105(8). 2507–2514. 30 indexed citations
13.
Thomas, Vinay Mathew, et al.. (2020). 1608P Publication rate and characteristics of cancer clinical trials in India. Annals of Oncology. 31. S968–S968. 1 indexed citations
14.
Trapani, Dario, et al.. (2019). More options for adjuvant treatment of HER2‐positive breast cancer: How to choose wisely?. International Journal of Cancer. 145(11). 2901–2906. 12 indexed citations
15.
Croessmann, Sarah, Luigi Formisano, Lisa N. Kinch, et al.. (2018). Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer. Clinical Cancer Research. 25(1). 277–289. 78 indexed citations
16.
Patel, Reema, S. C. Maxwell, Donglin Yan, et al.. (2017). Medical oncologists’ perception of antiestrogen therapy benefit in premenopausal women with hormone receptor-positive early-stage breast cancer. Annals of Oncology. 29(3). 772–773. 1 indexed citations
17.
Mathew, Aju, Padma Sheila Rajagopal, Gurprataap Singh Sandhu, et al.. (2017). Distinct Pattern of Metastases in Patients with Invasive Lobular Carcinoma of the Breast. Geburtshilfe und Frauenheilkunde. 77(6). 660–666. 71 indexed citations
18.
Mathew, Aju & Edward H. Romond. (2016). Systemic therapy for HER2-positive early-stage breast cancer. Current Problems in Cancer. 40(2-4). 106–116. 7 indexed citations
19.
Mathew, Aju & Nancy E. Davidson. (2015). Adjuvant endocrine therapy for premenopausal women with hormone-responsive breast cancer. The Breast. 24. S120–S125. 15 indexed citations
20.
Seidel, D., et al.. (2009). The association between body mass index and Barrett's esophagus: a systematic review. Diseases of the Esophagus. 22(7). 564–570. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026